Veeral Desai, Chief Strategy & Development Officer at agilon health, inc. (AGL), sold 10,045 shares at $26.82 ($270K) on 2023-04-19, disclosed to the SEC on 2023-04-21.
Scheduled sale ($270k) by Chief Strategy & Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.82 | 4,545 | $122K | 45.2% |
| 2 | $26.82 | 4,545 | $122K | 45.2% |
| 3 | $27.84 | 455 | $13K | 4.7% |
| 4 | $26.15 | 500 | $13K | 4.9% |
| Total | $26.83 avg | 10,045 | $270K | 100% |
| Filing → |
| AGL | SELL | 2023-03-17 | $1.6M | — | Filing → |
| AGL | SELL | 2022-07-25 | $2.2M | — | Filing → |
| AGL | SELL | 2022-07-11 | $8.0M | — | Filing → |